Clinical trials
Retinal Degeneration trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Editas Medicine, Inc. | 1 |
| NGoggle | 1 |
| OccuLogix | 1 |
| Theragenics Corporation | 1 |
| Tufts University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Degeneration | 5 |
| Macular Degeneration | 4 |
| Retinal Diseases | 3 |
| Choroidal Neovascularization | 1 |
| Congenital Abnormalities | 1 |
| Eye Abnormalities | 1 |
| Eye Diseases | 1 |
| Eye Diseases, Hereditary | 1 |
| Genetic Diseases, Inborn | 1 |
| Glaucoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.